Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0153
+0.0011 (7.75%)
Feb 12, 2026, 9:30 AM EST
Nu-Med Plus Market Cap
Nu-Med Plus has a market cap or net worth of $1.28 million as of February 13, 2026. Its market cap has decreased by -49.00% in one year.
Market Cap
1.28M
Enterprise Value
1.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since September 25, 2014, Nu-Med Plus's market cap has decreased from 24.57M to 1.28M, a decrease of -94.80%. That is a compound annual growth rate of -22.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 1.28M | -11.46% |
| Dec 29, 2025 | 1.44M | 12.58% |
| Dec 31, 2024 | 1.28M | -62.05% |
| Dec 28, 2023 | 3.38M | 151.78% |
| Dec 30, 2022 | 1.34M | -51.67% |
| Dec 31, 2021 | 2.78M | -93.86% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vycor Medical | 3.67M |
| Ludwig Enterprises | 3.58M |
| Fuse Medical | 2.89M |
| AI Maverick Intel | 1.89M |
| Lifeline Biotechnologies | 1.74M |
| Escalon Medical | 1.43M |
| St. Joseph | 1.27M |
| Venus Concept | 755.27K |